Skip to content

Megna Michael R Insider Trading -- Recent SEC Form 4 Transactions

Megna Michael R (CIK 1464583) reported 39 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-03). Recent activity: Buy KNSA (3,932 shares), Buy KNSA (279 shares), Buy KNSA (2,558 shares), Buy KNSA (2,362 shares), Buy KNSA (2,644 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy3,932$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy279$9,346
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy2,558$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy2,362$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy2,644$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell5,531$438,498
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell4,600$369,380
2026-04-13Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell6,625$309,321
2026-04-08Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy3,932$3,932
2026-04-08Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell1,666$81,534
2026-04-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell3,205$154,257
2026-04-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy7,564$0
2026-04-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy372$8,988
2025-10-22Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy791$12,260
2025-10-22Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy9,831$109,124
2025-10-22Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy9,831$117,677
2025-10-22Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy12,787$137,588
2025-10-22Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell37,255$1.4M
2025-10-22Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell13,235$520,268
2025-10-22Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy6,195$80,349
2025-10-08Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy175$0
2025-10-08Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERSell85$3,272
2025-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy3,933$0
2025-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy2,363$0
2025-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF ACCOUNTING OFFICERBuy2,557$0

Source: SEC Form 4 filings · as of 2026-09-03